Durect Corp (DRRX)
1.03
-0.17
(-14.17%)
USD |
NASDAQ |
May 08, 16:00
1.03
0.00 (0.00%)
After-Hours: 17:55
Durect Free Cash Flow: -34.47M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -34.47M |
| September 30, 2023 | -34.57M |
| June 30, 2023 | -29.33M |
| March 31, 2023 | -30.06M |
| December 31, 2022 | -26.39M |
| September 30, 2022 | -29.08M |
| June 30, 2022 | -34.35M |
| March 31, 2022 | -32.38M |
| December 31, 2021 | -37.50M |
| September 30, 2021 | -34.79M |
| June 30, 2021 | -35.99M |
| March 31, 2021 | -36.63M |
| December 31, 2020 | -38.91M |
| September 30, 2020 | -26.60M |
| June 30, 2020 | 0.906M |
| March 31, 2020 | 3.671M |
| December 31, 2019 | 10.95M |
| September 30, 2019 | 0.924M |
| June 30, 2019 | -18.92M |
| March 31, 2019 | -18.85M |
| December 31, 2018 | -19.84M |
| September 30, 2018 | -21.14M |
| June 30, 2018 | -17.44M |
| March 31, 2018 | 0.999M |
| December 31, 2017 | -1.412M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.469M |
| June 30, 2017 | -9.959M |
| March 31, 2017 | -30.17M |
| December 31, 2016 | -27.44M |
| September 30, 2016 | -26.00M |
| June 30, 2016 | -25.52M |
| March 31, 2016 | -22.10M |
| December 31, 2015 | -21.06M |
| September 30, 2015 | -18.02M |
| June 30, 2015 | -17.38M |
| March 31, 2015 | -17.40M |
| December 31, 2014 | -14.76M |
| September 30, 2014 | -15.65M |
| June 30, 2014 | -14.85M |
| March 31, 2014 | -14.83M |
| December 31, 2013 | -15.52M |
| September 30, 2013 | -15.45M |
| June 30, 2013 | -14.30M |
| March 31, 2013 | -12.71M |
| December 31, 2012 | -13.74M |
| September 30, 2012 | -14.34M |
| June 30, 2012 | -13.94M |
| March 31, 2012 | -15.89M |
| December 31, 2011 | -19.85M |
| September 30, 2011 | -19.15M |
Free Cash Flow Range, Past 5 Years
-38.91M
Minimum
Dec 2020
10.95M
Maximum
Dec 2019
-24.40M
Average
-30.06M
Median
Mar 2023
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.325M |
| Cash from Investing (Quarterly) | -1.034M |
| Cash from Financing (Quarterly) | -1.226M |
| Free Cash Flow Per Share (Quarterly) | -0.2795 |
| Free Cash Flow to Equity (Quarterly) | -6.288M |
| Free Cash Flow Yield | -126.6% |